USPTO serial 79266160
CYMERE
Reviewed by CopyMark Law Group
Status 401
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAVACHE, LINDA M
- Law office
- TMEG LAW OFFICE 106
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CYMERE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Cellular function activating agents for medical purposes; therapeutic pharmaceutical for the treatment of wounds, skin conditions, orthopaedic conditions including sarcopenia, osteoarthritis and tendinopathy, degenerative eye disease including age related macular degeneration, age related conditions, neurodegenerative disease, depression, bleeding, trauma, stroke, heart disease | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 18, 2021 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jul 17, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Feb 22, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 8, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 3, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 18, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 26, 2020 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 25, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 26, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 26, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 26, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 5, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 4, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 30, 2019 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Oct 10, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 9, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 13, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 9, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 29, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |